| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.05 |
| mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.05 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.06 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.06 |
| mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.06 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.06 |